Summary of Product Characteristics
last updated on the eMC:
18/09/2007
|
SPC
|
Minims Fluorescein Sodium
|
Go to top of the page | Minims Fluorescein Sodium 2% | |
Go to top of the page | 2% w/v solution of Fluorescein Sodium PhEur. | |
Go to top of the page | Single-use, sterile eye drops. | |
Go to top of the pageGo to top of the page | As a diagnostic stain. Fluorescein does not stain a normal cornea but conjunctival abrasions are stained yellow or orange, corneal abrasions or ulcers are stained a bright green and foreign bodies are surrounded by a green ring. Fluorescein can be used in diagnostic examinations including Goldmann tonometry and in the fitting of hard contact lenses. | |
Go to top of the page | Adults, Children and the Elderly Instil dropwise into the eye. Sufficient solution should be applied to stain the damaged areas. Excess may be washed away with sterile saline solution. | |
Go to top of the page | Not to be used with soft contact lenses. | |
Go to top of the page | Special care should be taken to avoid microbial contamination. Pseudomonas aeruginosa grows well in fluorescein solutions, therefore, a single dose solution is preferred. Each Minims unit should be discarded after a single use. | |
Go to top of the pageGo to top of the page | Safety for use in pregnancy and lactation has not been established, therefore use only when considered essential by the physician. | |
Go to top of the page | May cause transient blurring of vision on instillation. Warn patients not to drive or operate hazardous machinery until vision is clear. | |
Go to top of the page | ADRs are very rare(<1/10,000),including isolated reports. Symptoms of allergic-type reactions and anaphylaxis have been reported following topical ophthalmic administration of Fluorescein sodium and may manifest as:Eye disorders: allergic conjunctivitis, peri-orbital oedemaImmune system disorders: anaphylactic reaction Skin and subcutaneous tissue disorders: urticaria, rash | |
Go to top of the page | Overdose following the recommended use is unlikely. | |
Go to top of the pageGo to top of the page | Fluorescein acts as a diagnostic stain. | |
Go to top of the page | Fluorescein will resist penetration of a normal cornea and most excess solution will, therefore, be carried with the tear film away from the conjunctival sac. The majority will be lost through the naso-lacrimal ducts and absorbed via the gastro-intestinal tract from where it is converted rapidly to its glucuronide and excreted via the urine. If fluorescein crosses the cornea it will enter the Bowman's membrane, stroma and possibly the anterior chamber. Aqueous flow and diffusion into the blood in the anterior chamber finally removes fluorescein from the eye and it is excreted unchanged in the urine. | |
Go to top of the page | There are no preclinical data of relevance to the prescriber which are additional to that already included in other sections of this SPC. | |
Go to top of the pageGo to top of the pageGo to top of the pageGo to top of the pageGo to top of the page | Store below 25°C. Do not freeze. Protect from light. | |
Go to top of the page | A sealed conical shaped polypropylene container fitted with a twist and pull off cap. Each Minims unit contains approximately 0.5ml of solution. Each unit is overwrapped in a polypropylene/paper pouch. 20 units are packed into a suitable carton. | |
Go to top of the page | Each Minims unit should be discarded after use. | |
Go to top of the page | Chauvin Pharmaceuticals Ltd 106 London Road Kingston-upon-Thames Surrey KT2 6TN | |
Go to top of the pageGo to top of the page | Date of first Authorisation: 23 April 1987 Date of renewal of Authorisation: 18 February 1992 | |
Go to top of the page
More information about this product
Link to this document from your website: http://www.medicines.org.uk/emc/medicine/421/SPC/